107 results match your criteria: "University Hospital Antwerpen[Affiliation]"

Currently, the rising prevalence of resistant species, particularly , as well as non-albicans isolates such as and , represent challenges in their management. In this review, we aimed to explore the current management of fluconazole-resistant vulvovaginal candidiasis (FRVVC). Identified studies focused on alternative antifungal therapies, including boric acid, nystatin, and newer agents like oteseconazole and ibrexafungerp.

View Article and Find Full Text PDF
Article Synopsis
  • - Vulvovaginal candidosis (VVC) is a prevalent condition among women, but existing diagnostic methods are often inefficient and result in delayed treatment due to the need for specialized training and lengthy processes.
  • - A review of 23 studies showed that molecular diagnostic tools, particularly NAAT/PCR assays, have high sensitivity and specificity for VVC compared to traditional methods, while simpler DNA probes have lower sensitivity.
  • - Despite the advancements in molecular diagnostics, traditional methods still play an important role, especially in settings with limited resources, and emerging technologies like AI show potential to further enhance diagnosis and treatment outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • Vulvovaginal candidosis (VVC) is a common and troublesome vaginal infection, and many patients experience recurrent cases even after antifungal treatment.
  • Probiotics may serve as a useful alternative or complementary treatment option for managing VVC, as studies suggest they could improve patient outcomes, even though current findings on their effectiveness are mixed.
  • The research indicates that while antifungals like fluconazole are still more effective, combining them with probiotics could help reduce recurrence and improve symptoms, prompting a need for more targeted future studies on probiotics' roles in VVC treatment and prevention.
View Article and Find Full Text PDF
Article Synopsis
  • The optimal management of patients with atrial fibrillation (AF) requiring oral anticoagulation (OAC) during percutaneous coronary intervention (PCI) is debated, with current guidelines suggesting a temporary triple therapy regimen that includes aspirin, which raises bleeding risks.
  • A new study, the WOEST-3 trial, seeks to compare a 30-day dual antiplatelet therapy (DAPT) strategy that temporarily omits OAC against guideline-directed therapy post-PCI for AF patients, aiming to reduce bleeding without sacrificing efficacy.
  • With a sample of 2,000 patients, the trial will evaluate the rates of major bleeding and adverse ischemic events, making it the first randomized controlled trial to explore the omission of OAC
View Article and Find Full Text PDF

Peripheral muscle force balance/imbalance in neurological binary control of bladder function and dysfunction.

Ann Transl Med

April 2024

Department of Urology, Faculty of Medicine and Health Sciences, University Hospital Antwerpen, University of Antwerpen, Antwerpen, Belgium.

Bladder control is not from the bladder itself but from muscles and ligaments outside of it. Bladder control is binary, either closed or open. Control is exerted cortically, directly and via a peripheral pelvic mechanism comprising three reflex pelvic muscles which contract (variously) against pubourethral ligaments (PULs) anteriorly and uterosacral ligaments (USLs) posteriorly.

View Article and Find Full Text PDF

Head-to-Head Comparison of 2 Paclitaxel-Coated Balloons for Femoropopliteal Lesions.

JACC Cardiovasc Interv

December 2023

Department of Vascular Surgery, AZ Sint Blasius, Dendermonde, Belgium.

Background: There is a scarcity of published head-to-head comparisons between different paclitaxel-coated angioplasty balloons. More prospective safety data to support the health care economic reimbursement processes are needed.

Objectives: The aim of this study was to report the safety and efficacy of the Passeo-18 Lux drug-coated balloon (DCB) (Biotronik AG) for the treatment of symptomatic peripheral artery disease caused by stenosis, restenosis, or occlusion of the femoral and/or popliteal arteries.

View Article and Find Full Text PDF

SARS-CoV-2 infection reduces quality of sperm parameters: prospective one year follow-up study in 93 patients.

EBioMedicine

July 2023

Femicare, Clinical Research for Women, Tienen, Belgium; University Hospital Antwerpen, Antwerp, Belgium; Department of Obstetrics and Gynecology, Regional Hospital Heilig Hart, Tienen, Belgium.

Background: Short- and long-term implications of SARS-CoV-2 on the quality of the sperm and the results of this on fertility remain largely unknown due to lack of longitudinal studies. In this longitudinal observational cohort study, we aimed to analyse the differential effect and the impact of SARS-CoV-2 infection on different semen quality parameters.

Methods: Sperm quality was assessed using the World Health Organization criteria, DNA damage to sperm cells by quantifying the DNA fragmentation index (DFI) and the high-density stainability (HDS), IgA- and IgG-anti-sperm antibodies (ASA) were assessed with light microscopy.

View Article and Find Full Text PDF

Aim: Determine incidence of visual impairment due to retinopathy of prematurity (ROP) and concomitant disabilities between 2009 and 2018 in the Netherlands and compare data to four former similar studies. Secondly, monitor if infants were missed for ROP-screening since the adoption of stricter, risk factor guided criteria (2013).

Methods: Retrospective inventory on anonymous data of infants diagnosed with ROP from Dutch visual impairment-institutes.

View Article and Find Full Text PDF

Background: Nausea and vomiting in pregnancy (NVP) affects 50-80% of pregnant women and is correlated to the level of human chorionic gonadotropin (hCG). Hyperemesis gravidarum (HG) is a severe condition, with an incidence of 0.2-1.

View Article and Find Full Text PDF

Controversies remain regarding the preferred treatment strategy for central introital dyspareunia. The primary goal of this retrospective study was to evaluate the short- and long-term outcomes after operative management of central introital dyspareunia by widening hymenoplasty. In total, 513 patients were included, with a follow-up time of 10 years.

View Article and Find Full Text PDF

is a frequent condition, and although several risk factors are known, its behavior is still enigmatic. The seasonal influence of climate conditions and living habits on its prevalence was studied. In a retrospective lab-based cohort over 10 years, we studied the prevalence of in 12,941 vaginal cultures taken from women attending a vulvovaginitis clinic.

View Article and Find Full Text PDF

Sperm quality and absence of SARS-CoV-2 RNA in semen after COVID-19 infection: a prospective, observational study and validation of the SpermCOVID test.

Fertil Steril

February 2022

Department of Hormonology and Reproductive Health, Algemeen Medisch Laboratorium (AML), Sonic Healthcare, Antwerp, Belgium; Department of Clinical and Molecular Pathology, AML, Sonic Healthcare, Antwerp, Belgium.

Objective: To study the contagiousness of sperm and its influence on fertility after recovery from COVID-19 infection.

Design: Prospective cohort study.

Setting: University medical center.

View Article and Find Full Text PDF

Objectives: In some patients treated for urinary or fecal incontinence with sacral neuromodulation (SNM) persistence of symptoms, a reduction in efficacy or adverse effects of stimulation can occur. In such situations, further programming of the SNM device can help resolve problems. Infrequently hardware failure is detected.

View Article and Find Full Text PDF

: Unexplained bone marrow edema on MRI warrants further investigation with CT to demonstrate a nidus which is pathognomonic for an osteoid osteoma.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to establish a sperm DNA fragmentation index (DFI) cutoff of 26% associated with clinical pregnancies during intra-uterine insemination (IUI) and evaluate the impact of Human Papillomavirus (HPV) on sperm DNA damage.
  • In a multi-center study with 161 infertile couples undergoing 209 IUI cycles, results showed that couples with a male DFI above 26% experienced significantly lower clinical pregnancy rates compared to those below this threshold (OR 0.0326).
  • HPV was present in 14.8% of sperm samples and was linked to higher DFI levels (29.8% vs. 20.9% for HPV
View Article and Find Full Text PDF

Lenalidomide, an antineoplastic and immunomodulatory drug, has therapeutic activity in acute myeloid leukemia (AML), but definitive studies about its therapeutic utility have been lacking. In a phase 3 study, we compared 2 induction regimens in newly diagnosed patients age 18 to 65 years with AML: idarubicine-cytarabine (cycle 1) and daunorubicin and intermediate-dose cytarabine (cycle 2) without or with lenalidomide (15 mg orally on days 1-21). One final consolidation cycle of chemotherapy or autologous stem cell transplantation (auto-SCT) or allogeneic SCT (allo-SCT) was provided according to a prognostic risk and minimal residual disease (MRD)-adapted approach.

View Article and Find Full Text PDF

Objectives: Development and implementation of SARS-CoV-2 serologic assays gained momentum. Laboratories keep on investigating the performance of these assays. In this study, we compared three fully automated SARS-CoV-2 antibody assays.

View Article and Find Full Text PDF
Article Synopsis
  • Sacral neuromodulation (SNM) is an effective treatment for urinary urgency incontinence (UUI), and the Axonics® System is the first rechargeable SNM approved for long-term use (15 years).
  • In a study with 129 UUI participants, 93% were considered therapy responders after 2 years, showing significant reductions in UUI episodes and improvements in quality of life.
  • All participants could recharge the device, with 94% finding the recharging process acceptable; results indicate the treatment's effectiveness is consistent across different demographics and severity levels.
View Article and Find Full Text PDF

The science behind programming algorithms for sacral neuromodulation.

Colorectal Dis

March 2021

Global Neuromodulation Research, Medtronic Inc, Minneapolis, Minnesota, USA.

Aim: Sacral neuromodulation (SNM) is a widely adopted treatment for overactive bladder, non-obstructive urinary retention and faecal incontinence. In the majority, it provides sustained clinical benefit. However, it is recognized that, even for these patients, stimulation parameters (such as amplitude, electrode configuration, frequency and pulse width) may vary at both initial device programming and at reprogramming, the latter often being required to optimize effectiveness.

View Article and Find Full Text PDF
Article Synopsis
  • The Axonics® System is a rechargeable sacral neuromodulation (SNM) device designed to treat voiding dysfunction, expected to last at least 15 years and reduce the need for replacement surgeries.
  • The ARTISAN-SNM study involved 129 patients with urinary urgency incontinence, utilizing various assessment tools to measure treatment efficacy.
  • After one year, 89% of participants had significant reductions in their symptoms, with high satisfaction ratings regarding device recharging and no serious adverse events reported.
View Article and Find Full Text PDF

Purpose Of Review: This review focuses on the use of point-of-care ultrasound (PoCUS) in the obstetric context for airway management and assessment of aspiration risk, the placement of neuraxial blocks and the diagnosis and follow-up of cardiorespiratory dysfunction.

Recent Findings: Gastric ultrasound is a useful aspiration risk assessment tool in pregnant patients. Total gastric fluid assessment models and specific cut-offs between high-risk and low-risk stomachs are presented.

View Article and Find Full Text PDF

Late-onset Pompe disease (LOPD) in Belgium: clinical characteristics and outcome measures.

Orphanet J Rare Dis

April 2020

Department of Neurology, Neuromuscular Reference Centre, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.

Background: Late-onset Pompe disease (LOPD) is a rare, hereditary, progressive disorder that is usually characterized by limb-girdle muscle weakness and/or respiratory insufficiency. LOPD is caused by mutations in the acid alpha-glucosidase (GAA) gene and treated with enzyme replacement therapy (ERT).

Methods: We studied the clinical, brain imaging, and genetic features of the Belgian cohort of late-onset Pompe disease patients (N = 52), and explored the sensitivity of different outcome measures, during a longitudinal period of 7 years (2010-2017), including the activity limitations ActivLim score, 6 min walking distance (6MWD), 10 m walk test (10MWT), MRC sum score, and forced vital capacity (FVC) sitting/supine.

View Article and Find Full Text PDF

Aims: Sacral neuromodulation (SNM) therapy for overactive bladder (OAB) has proven long-term safety and efficacy. Historically, the only commercially available SNM device was nonrechargeable requiring replacement surgery due to battery depletion. The Axonics System is the first rechargeable SNM device and is qualified to last a minimum of 15 years in the body.

View Article and Find Full Text PDF

Background: In sacral neuromodulation (SNM), stimulation programming plays a key role to achieve success of the therapy. However to date, little attention has been given to the best ways to set and optimize SNM programming during the test and chronic stimulation phases of the procedure.

Objective: Standardize and make SNM programming easier and more efficient for the several conditions for which SNM is proposed.

View Article and Find Full Text PDF